TC 5231Alternative Names: Mecamylamine; TC-5231
Latest Information Update: 13 Dec 2007
At a glance
- Originator Targacept
- Mechanism of Action Alpha4beta2 nicotinic receptor antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Attention-deficit hyperactivity disorder
Most Recent Events
- 06 Jul 2004 Phase-II clinical trials in Attention-deficit hyperactivity disorder in USA (unspecified route)